POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 131 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2023. The put-call ratio across all filers is 128.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,526,657 | -23.5% | 3,527,235 | +3.9% | 0.00% | -50.0% |
| Q2 2023 | $30,769,137 | +35.6% | 3,396,152 | +8.8% | 0.00% | +100.0% |
| Q1 2023 | $22,692,542 | -63.7% | 3,121,395 | -63.6% | 0.00% | -50.0% |
| Q4 2022 | $62,493,628 | +168.7% | 8,572,514 | +184.9% | 0.00% | +100.0% |
| Q3 2022 | $23,261,000 | +54.0% | 3,009,168 | +35.7% | 0.00% | 0.0% |
| Q2 2022 | $15,103,000 | +602.1% | 2,217,796 | +721.6% | 0.00% | – |
| Q1 2022 | $2,151,000 | +52.0% | 269,937 | +6.8% | 0.00% | – |
| Q4 2021 | $1,415,000 | -18.7% | 252,692 | +11.6% | 0.00% | – |
| Q3 2021 | $1,741,000 | – | 226,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,560,984 | $27,526,000 | 6.63% |
| Fairmount Funds Management LLC | 2,833,950 | $21,906,000 | 3.85% |
| JOHNSON & JOHNSON | 1,000,000 | $7,730,000 | 2.28% |
| BVF INC/IL | 5,590,048 | $43,211,000 | 1.78% |
| Affinity Asset Advisors, LLC | 746,576 | $5,771,000 | 1.61% |
| Sio Capital Management, LLC | 544,545 | $4,209,000 | 1.34% |
| PFM Health Sciences, LP | 4,515,216 | $34,903,000 | 1.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,052,842 | $8,138,000 | 1.13% |
| Boxer Capital, LLC | 2,500,000 | $19,325,000 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $2,319,000 | 0.78% |